TAMPA, Fla., March 2, 2005 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), a leading source of low-cost prescription medications and diagnostic lab testing for the millions of Americans who have no insurance coverage, announces internal restructuring to maximize shareholder value. The restructuring includes the hiring of an outside payroll company, realignment of corporate positions and the hiring of an outside auditing firm to verify governmental and financial compliance.
Peter Fiorillo, CEO of Rx Processing commented, "I am encountering strong resistance in effecting this restructuring internally. This is toughest challenge as CEO I have undertaken to date but, if successful, all shareholders will be rewarded with timely financial reports and transparency in all company matters affecting the business."
Americans who have no prescription insurance coverage or lab testing coverage have turned to Rx Processing, which offers FDA-approved American generic and low-cost Canadian brand name drugs with access to more than 3,000 FDA-approved patient service centers for their lab testing. Rx Processing's state-of-the-art technology finds the best prescription drug prices for these customers and members by sending their prescriptions to licensed pharmacies or lab order to the closest patient center to be serviced. Rx Processing provides access to prescription drugs, lab testing and drug testing for the 40 million Americans without prescription drug coverage who spend billions of dollars on their prescription drugs, lab testing and drug testing each year.
Rx Processing is rapidly becoming a market leader in providing prescription drugs, lab tests and drug tests to U.S. citizens, corporations, unions, and members through FDA-approved patient service centers for their Lab testing and licensed pharmacies in the United States and Canada. The Company provides access to more than 1,500 approved brand name and generic medications and provides access to over 1,000 diagnostic tests including: heart disease risk assessment, cancer detection and several other wellness tests and early detection diagnostics ready for distribution an service in the U.S. market through its company-owned and operated storefront locations and over 130 affiliated storefronts with access to 3,000 FDA-approved patient service centers. By utilizing Rx Processing, U.S. citizens can save up to 84% on their daily prescriptions up to 50% on their lab testing and drugs screening. Ordering these reduced cost medications and lab tests are available at the Company's affiliate retail storefronts and information about the company can be found at www.rxprocessingcorp.com.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.